Nokia Oyj (HEL:NOKIA) PT Set at €4.50 by UBS Group

Share on StockTwits

Nokia Oyj (HEL:NOKIA) has been assigned a €4.50 ($5.23) price objective by analysts at UBS Group in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock.

Several other analysts have also weighed in on the company. Barclays set a €3.50 ($4.07) price objective on Nokia Oyj and gave the company a “neutral” rating in a report on Wednesday. Deutsche Bank set a €4.20 ($4.88) target price on Nokia Oyj and gave the company a “buy” rating in a report on Thursday, October 31st. Morgan Stanley set a €3.70 ($4.30) target price on Nokia Oyj and gave the company a “neutral” rating in a report on Tuesday, January 14th. JPMorgan Chase & Co. set a €3.75 ($4.36) target price on Nokia Oyj and gave the company a “neutral” rating in a report on Thursday, February 6th. Finally, Goldman Sachs Group set a €2.90 ($3.37) target price on Nokia Oyj and gave the company a “sell” rating in a report on Thursday, February 6th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company’s stock. Nokia Oyj presently has a consensus rating of “Hold” and a consensus target price of €4.11 ($4.77).

Nokia Oyj has a twelve month low of €3.81 ($4.43) and a twelve month high of €5.95 ($6.92).

About Nokia Oyj

Nokia Oyj is a Finland-based company engaged in the network and Internet protocol (IP) infrastructure, software, and related services market. The Company’s businesses include Nokia Networks and Nokia Technologies. The Company’s segments include Ultra Broadband Networks, IP Networks and Applications, and Nokia Technologies.

Recommended Story: Mutual Funds

Analyst Recommendations for Nokia Oyj (HEL:NOKIA)

Receive News & Ratings for Nokia Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nokia Oyj and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.